Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04107077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Jun 1, 2030 to Aug 20, 2026
    • Study completion moved earlier from Jun 1, 2030 to Dec 20, 2026
    v11
  2. Primary and study completion dates: Jun 1, 2026 to Jun 1, 2030v10
  3. Start date: Mar 14, 2024 to Sep 9, 2025v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary completion date: Jun 1, 2024 to Jun 1, 2026
    • Study completion date: Jun 1, 2025 to Jun 1, 2026
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Start date: Nov 11, 2019 to Mar 14, 2024v6
  2. Primary completion date: Jun 1, 2023 to Jun 1, 2024
    • Site contact updated
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Site contact updatedv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2020 to Nov 11, 2019
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess if PD-L1 expression can be upregulated in peritoneal metastases from gastric cancer after the administration of HIPEC with greater frequency compared to systemic chemotherapy alone
Trial Details
NCT Number NCT04107077
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Gastric Cancer, Peritoneal Carcinomatosis
Related terms Peritoneal Neoplasms, Stomach Neoplasms
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov